|
1
|
Zuberbier T, Aberer W, Asero R, Abdul
Latiff AH, Baker D, Ballmer-Weber B, Bernstein JA, Bindslev-Jensen
C, Brzoza Z, Buense Bedrikow R, et al: The EAACI/GA²LEN/EDF/WAO
guideline for the definition, classification, diagnosis and
management of urticaria. Allergy. 73:1393–1414. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mathias SD, Crosby RD, Zazzali JL, Maurer
M and Saini SS: Evaluating the minimally important difference of
the urticaria activity score and other measures of disease activity
in patients with chronic idiopathic urticaria. Ann Allergy Asthma
Immunol. 108:20–24. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Weller K, Groffik A, Magerl M, Tohme N,
Martus P, Krause K, Metz M, Staubach P and Maurer M: Development
and construct validation of the angioedema quality of life
questionnaire. Allergy. 67:1289–1298. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hawro T, Ohanyan T, Schoepke N, Metz M,
Peveling-Oberhag A, Staubach P, Maurer M and Weller K: The
urticaria activity score-validity, reliability, and responsiveness.
J Allergy Clin Immunol Pract. 6:1185–1190.e1. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hawro T, Ohanyan T, Schoepke N, Metz M,
Peveling-Oberhag A, Staubach P, Maurer M and Weller K: Comparison
and interpretability of the available urticaria activity scores.
Allergy. 73:251–255. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Baiardini I, Braido F, Bindslev-Jensen C,
Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens
W, Gerth van Wijk R, et al: Recommendations for assessing
patient-reported outcomes and health-related quality of life in
patients with urticaria: A GA(2) LEN taskforce position paper.
Allergy. 66:840–844. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Maurer M, Staubach P, Raap U, Richter-Huhn
G, Bauer A, Ruëff F, Jakob T, Yazdi AS, Mahler V, Wagner N, et al:
H1-antihistamine-refractory chronic spontaneous urticaria: It's
worse than we thought-first results of the multicenter real-life
AWARE study. Clin Exp Allergy. 47:684–692. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Maurer M, Staubach P, Raap U, Richter-Huhn
G, Baier-Ebert M and Chapman-Rothe N: ATTENTUS, a German online
survey of patients with chronic urticaria highlighting the burden
of disease, unmet needs and real-life clinical practice. Br J
Dermatol. 174:892–894. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Maurer M, Abuzakouk M, Bérard F, Canonica
W, Oude Elberink H, Giménez-Arnau A, Grattan C, Hollis K, Knulst A,
Lacour JP, et al: The burden of chronic spontaneous urticaria is
substantial: Real-world evidence from ASSURE-CSU. Allergy.
72:2005–2016. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
O'Donnell BF, Lawlor F, Simpson J, Morgan
M and Greaves MW: The impact of chronic urticaria on the quality of
life. Br J Dermatol. 136:197–201. 1997.PubMed/NCBI
|
|
11
|
Parisi CA, Ritchie C, Petriz N and Morelo
Torres C: Direct medical costs of chronic urticaria in a private
health organization of Buenos Aires, Argentina. Value Health Reg
Issues. 11:57–59. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Broder MS, Raimundo K, Antonova E and
Chang E: Resource use and costs in an insured population of
patients with chronic idiopathic/spontaneous urticaria. Am J Clin
Dermatol. 16:313–321. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Graham J, McBride D, Stull D, Halliday A,
Alexopoulos ST, Balp MM, Griffiths M, Agirrezabal I, Zuberbier T
and Brennan A: Cost utility of omalizumab compared with standard of
care for the treatment of chronic spontaneous urticaria.
Pharmacoeconomics. 34:815–827. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Church MK, Kolkhir P, Metz M and Maurer M:
The role and relevance of mast cells in urticaria. Immunol Rev.
282:232–247. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Peteiro C and Toribio J: Incidence of
leukocytoclastic vasculitis in chronic idiopathic urticaria. Study
of 100 cases. Am J Dermatopathol. 11:528–533. 1989.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ito Y, Satoh T, Takayama K, Miyagishi C,
Walls AF and Yokozeki H: Basophil recruitment and activation in
inflammatory skin diseases. Allergy. 66:1107–1113. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kay AB, Clark P, Maurer M and Ying S:
Elevations in T-helper-2-initiating cytokines (interleukin-33,
interleukin-25 and thymic stromal lymphopoietin) in lesional skin
from chronic spontaneous (‘idiopathic’) urticaria. Br J Dermatol.
172:1294–1302. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kay AB, Ying S, Ardelean E, Mlynek A, Kita
H, Clark P and Maurer M: Calcitonin gene-related peptide and
vascular endothelial growth factor are expressed in lesional but
not uninvolved skin in chronic spontaneous urticaria. Clin Exp
Allergy. 44:1053–1060. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zuberbier T, Schadendorf D, Haas N,
Hartmann K and Henz BM: Enhanced P-selectin expression in chronic
and dermographic urticaria. Int Arch Allergy Immunol. 114:86–89.
1997.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kay AB, Ying S, Ardelean E, Mlynek A, Kita
H, Clark P and Maurer M: Elevations in vascular markers and
eosinophils in chronic spontaneous urticarial weals with low-level
persistence in uninvolved skin. Br J Dermatol. 171:505–511.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Greaves MW: Chronic urticaria. N Engl J
Med. 332:1767–1772. 1995.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kaplan AP: Clinical practice. Chronic
urticaria and angioedema. N Engl J Med. 346:175–179.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hermes B, Prochazka AK, Haas N, Jurgovsky
K, Sticherling M and Henz BM: Upregulation of TNF-alpha and IL-3
expression in lesional and uninvolved skin in different types of
urticaria. J Allergy Clin Immunol. 103:307–314. 1999.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Haas N, Schadendorf D and Henz BM:
Differential endothelial adhesion molecule expression in early and
late whealing reactions. Int Arch Allergy Immunol. 115:210–214.
1998.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rorsman H: Basophilic leucopenia in
different forms of urticaria. Acta Allergol. 17:168–184.
1962.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gruber BL, Baeza ML, Marchese MJ, Agnello
V and Kaplan AP: Prevalence and functional role of anti-IgE
autoantibodies in urticarial syndromes. J Invest Dermatol.
90:213–217. 1988.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Grattan CE, Wallington TB, Warin RP,
Kennedy CT and Bradfield JW: A serological mediator in chronic
idiopathic urticaria-a clinical, immunological and histological
evaluation. Br J Dermatol. 114:583–590. 1986.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Grattan CE, Boon AP, Eady RA and
Winkelmann RK: The pathology of the autologous serum skin test
response in chronic urticaria resembles IgE-mediated late-phase
reactions. Int Arch Allergy Appl Immunol. 93:198–204.
1990.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Grattan CE, Francis DM, Hide M and Greaves
MW: Detection of circulating histamine releasing autoantibodies
with functional properties of anti-IgE in chronic urticaria. Clin
Exp Allergy. 21:695–704. 1991.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hide M, Francis DM, Grattan CE, Hakimi J,
Kochan JP and Greaves MW: Autoantibodies against the high-affinity
IgE receptor as a cause of histamine release in chronic urticaria.
N Engl J Med. 328:1599–1604. 1993.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kolkhir P, Metz M, Altrichter S and Maurer
M: Comorbidity of chronic spontaneous urticaria and autoimmune
thyroid diseases: A systematic review. Allergy. 72:1440–1460.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Puccetti A, Bason C, Simeoni S, Millo E,
Tinazzi E, Beri R, Peterlana D, Zanoni G, Senna G, Corrocher R and
Lunardi C: In chronic idiopathic urticaria autoantibodies against
Fc epsilonRII/CD23 induce histamine release via eosinophil
activation. Clin Exp Allergy. 35:1599–1607. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hatada Y, Kashiwakura J, Hayama K,
Fujisawa D, Sasaki-Sakamoto T, Terui T, Ra C and Okayama Y:
Significantly high levels of anti-dsDNA immunoglobulin E in sera
and the ability of dsDNA to induce the degranulation of basophils
from chronic urticaria patients. Int Arch Allergy Immunol. 161
(Suppl 2):S154–S158. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bracken SJ, Abraham S and MacLeod AS:
Autoimmune theories of chronic spontaneous urticaria. Front
Immunol. 10(627)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bansal CJ and Bansal AS: Stress,
pseudoallergens, autoimmunity, infection and inflammation in
chronic spontaneous urticaria. Allergy Asthma Clin Immunol.
15(56)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang M, Murphy RF and Agrawal DK:
Decoding IgE Fc receptors. Immunol Res. 37:1–16. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zuberbier T, Henz BM, Fiebiger E, Maurer D
and Stingl G: Anti-FcepsilonRIalpha serum autoantibodies in
different subtypes of urticaria. Allergy. 55:951–954.
2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Schmetzer O, Lakin E, Topal FA, Preusse P,
Freier D, Church MK and Maurer M: IL-24 is a common and specific
autoantigen of IgE in patients with chronic spontaneous urticaria.
J Allergy Clin Immunol. 142:876–882. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kolkhir P, Church MK, Weller K, Metz M,
Schmetzer O and Maurer M: Autoimmune chronic spontaneous urticaria:
What we know and what we do not know. J Allergy Clin Immunol.
139:1772–1781.e1. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Blank U, Ra C, Miller L, White K, Metzger
H and Kinet JP: Complete structure and expression in transfected
cells of high affinity IgE receptor. Nature. 337:187–189.
1989.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Turner H and Kinet JP: . Signalling
through the high-affinity IgE receptor Fc epsilonRI. Nature. 402
(Suppl 6760):B24–B30. 1999.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Panaszek B, Pawłowicz R, Grzegrzółka J and
Obojski A: Autoreactive IgE in chronic spontaneous/idiopathic
urticaria and basophil/mastocyte priming phenomenon, as a feature
of autoimmune nature of the syndrome. Arch Immunol Ther Exp
(Warsz). 65:137–143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Confino-Cohen R, Chodick G, Shalev V,
Leshno M, Kimhi O and Goldberg A: Chronic urticaria and
autoimmunity: Associations found in a large population study. J
Allergy Clin Immunol. 129:1307–1313. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rottem M: Chronic urticaria and autoimmune
thyroid disease: Is there a link? Autoimmun Rev. 2:69–72.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shin YS, Suh DH, Yang EM, Ye YM and Park
HS: Serum specific IgE to thyroid peroxidase activates basophils in
aspirin intolerant urticaria. J Korean Med Sci. 30:705–709.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Altrichter S, Peter HJ, Pisarevskaja D,
Metz M, Martus P and Maurer M: IgE mediated autoallergy against
thyroid peroxidase-a novel pathomechanism of chronic spontaneous
urticaria? PLoS One. 6(e14794)2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Altman K and Chang C: Pathogenic
intracellular and autoimmune mechanisms in urticaria and
angioedema. Clinic Rev Allerg Immunol. 45:47–62. 2013.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Krystel-Whittemore M, Dileepan KN and Wood
JG: Mast cell: A multi-functional master cell. Front Immunol.
6(620)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
da Silva EZ, Jamur MC and Oliver C: Mast
cell function: A new vision of an old cell. J Histochem Cytochem.
62:698–738. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Galli SJ and Tsai M: Mast cells in allergy
and infection: Versatile effector and regulatory cells in innate
and adaptive immunity. Eur J Immunol. 40:1843–1851. 2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jamur MC, Grodzki AC, Berenstein EH,
Hamawy MM, Siraganian RP and Oliver C: Identification and
characterization of undifferentiated mast cells in mouse bone
marrow. Blood. 105:4282–4289. 2005.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Metcalfe DD and Boyce JA: Mast cell
biology in evolution. J Allergy Clin Immunol. 117:1227–1229.
2006.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Collington SJ, Williams TJ and Weller CL:
Mechanisms underlying the localisation of mast cells in tissues.
Trends Immunol. 32:478–485. 2001.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Irani AA, Schechter NM, Craig SS, DeBlois
G and Schwartz LB: Two types of human mast cells that have distinct
neutral protease compositions. Proc Natl Acad Sci USA.
83:4464–4468. 1986.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Schwartz LB: Analysis of MC(T) and MC(TC)
mast cells in tissue. Methods Mol Biol. 315:53–62. 2006.PubMed/NCBI
|
|
56
|
Caproni M, Giomi B, Volpi W, Melani L,
Schincaglia E, Macchia D, Manfredi M, D'Agata A and Fabbri P:
Chronic idiopathic urticaria: Infiltrating cells and related
cytokines in autologous serum-induced wheals. Clin Immunol.
114:284–292. 2005.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Caproni M, Giomi B, Melani L, Volpi W,
Antiga E, Torchia D and Fabbri P: Cellular infiltrate and related
cytokines, chemokines, chemokine receptors and adhesion molecules
in chronic autoimmune urticaria: Comparison between spontaneous and
autologous serum skin test induced wheal. Int J Immunopathol
Pharmacol. 19:507–515. 2006.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Terhorst D, Koti I, Krause K, Metz M and
Maurer M: In chronic spontaneous urticaria, high numbers of dermal
endothelial cells, but not mast cells, are linked to recurrent
angio-oedema. Clin Exp Dermatol. 43:131–136. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Haas N, Toppe E and Henz BM: Microscopic
morphology of different types of urticaria. Arch Dermatol.
134:41–46. 1998.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Elias J, Boss E and Kaplan AP: Studies of
the cellular infiltrate of chronic idiopathic urticaria: Prominence
of T-lymphocytes, monocytes, and mast cells. J Allergy Clin
Immunol. 78:914–918. 1986.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Czarnetzki BM, Zwadlo-Klarwasser GZ,
Bröcker EB and Sorg C: Macrophage subsets in different types of
urticaria. Arch Dermatol Res. 282:93–97. 1990.PubMed/NCBI View Article : Google Scholar
|
|
62
|
English JS, Murphy GM, Winkelmann RK and
Bhogal B: A sequential histopathological study of dermographism.
Clin Exp Dermatol. 13:314–317. 1988.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kessler S and Kuhn C: Scanning electron
microscopy of mast cell degranulation. Lab Invest. 32:71–77.
1975.PubMed/NCBI
|
|
64
|
Toyoda M, Maruyama T, Morohashi M and
Bhawan J: Free eosinophil granules in urticaria: A correlation with
the duration of wheals. Am J Dermatopathol. 18:49–57.
1996.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Irwin RB, Lieberman P, Friedman MM,
Kaliner M, Kaplan R, Bale G, Treadwell G and Yoo TJ: Mediator
release in local heat urticaria: Protection with combined H1 and H2
antagonists. J Allergy Clin Immunol. 76:35–39. 1985.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Mayou SC, Kobza Black A, Eady RA and
Greaves MW: Cholinergic dermographism. Br J Dermatol. 115:371–377.
1986.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Mekori YA, Dobozin BS, Schocket AL, Kohler
PF and Clark RA: Delayed pressure urticaria histologically
resembles cutaneous late-phase reactions. Arch Dermatol.
124:230–235. 1988.PubMed/NCBI
|
|
68
|
Arai I, Tsuji M, Takeda H, Akiyama N and
Saito S: A single dose of interleukin-31 (IL-31) causes continuous
itch-associated scratching behaviour in mice. Exp Dermatol.
22:669–671. 2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Bodoor K, Al-Qarqaz F, Heis LA, Alfaqih
MA, Oweis AO, Almomani R and Obeidat MA: IL-33/13 axis and IL-4/31
axis play distinct roles in inflammatory process and itch in
psoriasis and atopic dermatitis. Clin Cosmet Investig Dermatol.
13:419–424. 2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Dillon SR, Sprecher C, Hammond A,
Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer
M, Harder B, Johnston J, et al: Interleukin 31, a cytokine produced
by activated T cells, induces dermatitis in mice. Nat Immunol.
5:752–760. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
71
|
Ezzat MH, Hasan ZE and Shaheen KY: Serum
measurement of interleukin-31 (IL-31) in paediatric atopic
dermatitis: Elevated levels correlate with severity scoring. J Eur
Acad Dermatol Venereol. 25:334–339. 2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Furue M, Yamamura K, Kido-Nakahara M,
Nakahara T and Fukui Y: Emerging role of interleukin-31 and
interleukin-31 receptor in pruritus in atopic dermatitis. Allergy.
73:29–36. 2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Gonzales AJ, Humphrey WR, Messamore JE,
Fleck TJ, Fici GJ, Shelly JA, Teel JF, Bammert GF, Dunham SA,
Fuller TE and McCall RB: Interleukin-31: Its role in canine
pruritus and naturally occurring canine atopic dermatitis. Vet
Dermatol. 24:48–53.e11-e22. 2013.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Kim S, Kim HJ, Yang HS, Kim E, Huh IS and
Yang JM: IL-31 serum protein and tissue mRNA levels in patients
with atopic dermatitis. Ann Dermatol. 23:468–473. 2011.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Lin W, Zhou Q, Liu C, Ying M and Xu S:
Increased plasma IL-17, IL-31, and IL-33 levels in chronic
spontaneous urticaria. Sci Rep. 7(17797)2017.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Zhang Q, Putheti P, Zhou Q, Liu Q and Gao
W: Structures and biological functions of IL-31 and IL-31
receptors. Cytokine Growth Factor Rev. 19:347–356. 2008.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Kasutani K, Fujii E, Ohyama S, Adachi H,
Hasegawa M, Kitamura H and Yamashita N: Anti-IL-31 receptor
antibody is shown to be a potential therapeutic option for treating
itch and dermatitis in mice. Br J Pharmacol. 171:5049–5058.
2014.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Moussion C, Ortega N and Girard JP: The
IL-1-like cytokine IL-33 is constitutively expressed in the nucleus
of endothelial cells and epithelial cells in vivo: A novel
‘alarmin’? PLoS One. 3(e3331)2008.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hsu CL, Neilsen CV and Bryce PJ: IL-33 is
produced by mast cells and regulates IgE-dependent inflammation.
PLoS One. 5(e11944)2010.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Saluja R, Khan M, Church MK and Maurer M:
The role of IL-33 and mast cells in allergy and inflammation. Clin
Transl Allergy. 5(33)2015.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Morita H, Arae K, Unno H, Miyauchi K,
Toyama S, Nambu A, Oboki K, Ohno T, Motomura K, Matsuda A, et al:
An interleukin-33-mast cell-interleukin-2 axis suppresses
papain-induced allergic inflammation by promoting regulatory T cell
numbers. Immunity. 43:175–186. 2015.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Hongjia L, Caiqing Z, Degan L, Fen L, Chao
W, Jinxiang W and Liang D: IL-25 promotes Th2 immunity responses in
airway inflammation of asthmatic mice via activation of dendritic
cells. Inflammation. 37:1070–1077. 2014.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Ikeda K, Nakajima H, Suzuki K, Kagami S,
Hirose K, Suto A, Saito Y and Iwamoto I: Mast cells produce
interleukin-25 upon Fc epsilon RI-mediated activation. Blood.
101:3594–3596. 2003.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Hepworth MR, Maurer M and Hartmann S:
Regulation of type 2 immunity to helminths by mast cells. Gut
Microbes. 3:476–481. 2012.PubMed/NCBI View Article : Google Scholar
|
|
85
|
West EE, Kashyap M and Leonard WJ: TSLP: A
key regulator of asthma pathogenesis. Drug Discov Today Dis Mech.
9(10)2012.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Ying S, O'Connor B, Ratoff J, Meng Q, Fang
C, Cousins D, Zhang G, Gu S, Gao Z, Shamji B, et al: Expression and
cellular provenance of thymic stromal lymphopoietin and chemokines
in patients with severe asthma and chronic obstructive pulmonary
disease. J Immunol. 181:2790–2798. 2008.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ying S, O'Connor B, Ratoff J, Meng Q,
Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, Lee TH and
Corrigan C: Thymic stromal lymphopoietin expression is increased in
asthmatic airways and correlates with expression of Th2-attracting
chemokines and disease severity. J Immunol. 174:8183–8190.
2005.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Hong GU, Ro JY, Bae Y, Kwon IH, Park GH,
Choi YH and Choi JH: Association of TG2 from mast cells and chronic
spontaneous urticaria pathogenesis. Ann Allergy Asthma Immunol.
117:290–297. 2016.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Maurer M, Altrichter S, Metz M, Zuberbier
T, Church MK and Bergmann KC: Benefit from reslizumab treatment in
a patient with chronic spontaneous urticaria and cold urticaria. J
Eur Acad Dermatol Venereol. 32:e112–e113. 2018.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Chang TW, Chen C, Lin CJ, Metz M, Church
MK and Maurer M: The potential pharmacologic mechanisms of
omalizumab in patients with chronic spontaneous urticaria. J
Allergy Clin Immunol. 135:337–342. 2015.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Altrichter S, Hawro T, Hänel K, Czaja K,
Lüscher B, Maurer M, Church MK and Baron JM: Successful omalizumab
treatment in chronic spontaneous urticaria is associated with
lowering of serum IL-31 levels. J Eur Acad Dermatol Venereol.
30:454–455. 2016.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Stellato C, de Paulis A, Ciccarelli A,
Cirillo R, Patella V, Casolaro V and Marone G: Anti-inflammatory
effect of cyclosporin A on human skin mast cells. J Invest
Dermatol. 98:800–804. 1992.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Harrison CA, Bastan R, Peirce MJ, Munday
MR and Peachell PT: Role of calcineurin in the regulation of human
lung mast cell and basophil function by cyclosporine and FK506. Br
J Pharmacol. 150:509–518. 2007.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Grattan CE, O'Donnell BF, Francis DM,
Niimi N, Barlow RJ, Seed PT, Kobza Black A and Greaves MW:
Randomized double-blind study of cyclosporin in chronic
‘idiopathic’ urticaria. Br J Dermatol. 143:365–372. 2000.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Vena GA, Cassano N, Colombo D, Peruzzi E
and Pigatto P: Neo-I-30 Study Group. Cyclosporine in chronic
idiopathic urticaria: A double-blind, randomized,
placebo-controlled trial. J Am Acad Dermatol. 55:705–709.
2006.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Kulthanan K, Chaweekulrat P, Komoltri C,
Hunnangkul S, Tuchinda P, Chularojanamontri L and Maurer M:
Cyclosporine for chronic spontaneous urticaria: A meta-analysis and
systematic review. J Allergy Clin Immunol Pract. 6:586–599.
2018.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Doshi DR and Weinberger MM: Experience
with cyclosporine in children with chronic idiopathic urticaria.
Pediatr Dermatol. 26:409–413. 2009.PubMed/NCBI View Article : Google Scholar
|
